High Cardiovascular Risk Management and Salt Reduction in Rural Villages in China

Sponsor
The George Institute for Global Health, China (Other)
Overall Status
Completed
CT.gov ID
NCT01259700
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
120
5
4
42
24
0.6

Study Details

Study Description

Brief Summary

Cardiovascular disease is the leading cause of death in China. At the village level, strategies for the control of cardiovascular disease are mostly absent. National clinical guidelines for the management of hypertension and cardiovascular disease are rarely disseminated to, or implemented by, the village primary care providers. Salt reduction has greater potential in rural China than almost anywhere else in the world. Very high levels of salt consumption, very little use of processed food and most dietary salt deriving from home cooking makes the removal of salt from the diet easier, cheaper and more worthwhile than in almost any other setting. The two large-scale cluster-randomized controlled trials proposed here will precisely and reliably define the effect of two highly plausible intervention strategies on important clinical outcomes. The evidence provided by the project will form the basis for policy setting that has the potential to greatly reduce the occurrence of vascular disease in rural China and take an important step towards balancing the rural urban divide in health and healthcare.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: High-risk patient standardized management package
  • Behavioral: Community based salt reduction program
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
China Rural Health Initiative: High Cardiovascular Risk Management and Salt Reduction in Rural Villages in China -- Two Parallel Large Cluster Randomized Controlled Trials
Study Start Date :
Dec 1, 2010
Actual Primary Completion Date :
Dec 1, 2012
Actual Study Completion Date :
Jun 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: High risk management

Behavioral: High-risk patient standardized management package
A primary-care based high cardiovascular risk management package delivered by village doctors
Other Names:
  • high risk management
  • Experimental: Salt reduction

    Behavioral: Community based salt reduction program
    A community-based salt reduction program delivered mainly by community health educators
    Other Names:
  • Salt reduction
  • Experimental: high risk management and salt reduction

    Behavioral: High-risk patient standardized management package
    A primary-care based high cardiovascular risk management package delivered by village doctors
    Other Names:
  • high risk management
  • Behavioral: Community based salt reduction program
    A community-based salt reduction program delivered mainly by community health educators
    Other Names:
  • Salt reduction
  • No Intervention: Usual care

    Outcome Measures

    Primary Outcome Measures

    1. Mean systematic blood pressure level [October 2010 - December 2012]

    2. 24 hour urinary sodium [October -December 2012]

    Secondary Outcome Measures

    1. 24 hour urinary potassium [October-December 2012]

    2. Urinary sodium:potassium ratio [October-December 2012]

    3. Receiving regular primary care [October 2010 -December 2012]

    4. Taking anti-hypertensive medications [October 2010 -December 2012]

    5. Taking aspirin [October 2010 -December 2012]

    6. Receiving therapeutic lifestyle recommendations from village doctors [Oct 2010 - Dec 2012]

    Other Outcome Measures

    1. Knowledge, attitude and behaviour relating to salt consumption [October-December 2012]

    2. Awareness, treatment, and control of hypertension [October 2010 - December 2012]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Physician-diagnosed history of coronary heart disease, ischemic stroke, or hemorrhagic stroke, or

    • Older age (50 years or older for men; 60 years or older for women) and having physician-diagnosed Type I or Type II diabetes

    • Older age (50 years or older for men; 60 years or older for women) and systolic blood pressure 160 mmHg (note that for simplicity, diastolic blood pressure is not included in the criteria)

    Exclusion Criteria:
    • none

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hebei Province Center for Disease Prevention and Control ,China Shijiazhuang Hebei China
    2 The First Hospital Of China Medical University Shenyang Liaoning China
    3 Ningxia Medical University School of Public Health Yinchuan Ningxia China
    4 Changzhi Medical College, China Changzhi Shanxi China
    5 The Xi'an Jiaotong University School of Public Health Xi'an Shanxi China

    Sponsors and Collaborators

    • The George Institute for Global Health, China
    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • Principal Investigator: Yangfeng Wu, PhD, The George Institute for Global Health, China

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    The George Institute for Global Health, China
    ClinicalTrials.gov Identifier:
    NCT01259700
    Other Study ID Numbers:
    • Pro00025963
    • HHSN268200900027C
    First Posted:
    Dec 14, 2010
    Last Update Posted:
    Feb 17, 2016
    Last Verified:
    Feb 1, 2016
    Keywords provided by The George Institute for Global Health, China
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 17, 2016